FOLH1 and breast cancer: Contrary to what the name suggests, PSMA is not only selective to prostate cancer cells [2, 3] but also expressed by neovascular endothelial cells of various cancers, including glioblastoma, kidney cancer, lung cancer, and breast cancer [4–6].